News

Hims & Hers Health, Inc. teams up with Novo Nordisk to offer Wegovy at $599/month, slashing costs. Click for why this is a ...
Hims & Hers (HIMS) stock popped more than 20% in trading early Tuesday after Novo Nordisk (NVO) announced a partnership with ...
Before taking a GLP-1, my usual breakfast would rely on carb-heavy items like a bagel with cream cheese, but now I prioritize ...
Some telehealth companies that offered compounded GLP-1s have disappeared altogether. Others are pursuing strategies that ...
Novo Nordisk has teamed up with Hims & Hers Health, LifeMD and Ro for cash-paying patients to access Wegovy injection 2.4 mg ...
TD Cowen downgraded Hims & Hers Health to "Hold" from "Buy" citing a lack of near-term catalysts and concerns over the company’s weight loss revenue guidance in a post-compounded GLP-1 ...
SHOPPING: Take steps to achieve your body goals with Hers, the weight loss program that takes into account your specific ...
Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...
In a joint venture with Novo Nordisk, Hims & Hers will dispense all doses of Wegovy to Americans who buy eligible subscriptions, with plans starting at $599 a month. The offering will launch this week ...
While these medications offer unprecedented health benefits, they come with challenges like cost, non-adherence and lack of ...
Millions of Americans are turning to popular GLP-1 drugs to help them lose weight — and while many have found weight loss success while taking these medicines, the number on ...